Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.

PLoS One · 2011 · PMC3101220 · PMID 21629699

Europe PMC DOI

hedged sentence

0.1100

closest p · 2.2× alpha

0.1100

boldest claim

The sentences

did not reach statistical significanceP = 0.11not close (p > 0.1)

There was a trend for a reduction in CFU counts between naïve animals and those vaccinated with MVA85A and Ad85A, but this did not reach statistical significance ( P = 0.11 and P = 0.16, respectively).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.